News

Printer Friendly Version View printer-friendly version
<< Back
Array BioPharma to Present at Leerink Swann Conference

BOULDER, Colo.--(BUSINESS WIRE)--May 5, 2008--Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the Leerink Swann Conquering Cancer with Novel Therapeutics: Roundtable Conference on May 9 in New York City. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.

Event: Leerink Swann Conquering Cancer with Novel Therapeutics: Roundtable Conference

Presenter: Robert E. Conway, Chief Executive Officer, Array BioPharma

Date: Friday, May 9, 2008

Time: 9:20 a.m. Eastern Time

Location: The Grand Hyatt New York, New York City

Webcast: www.arraybiopharma.com

About Array BioPharma

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer, inflammatory diseases and pain. Our proprietary drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target proteins and are aimed at significant unmet medical needs. In addition, leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas. For more information on Array, please go to www.arraybiopharma.com.

CONTACT: Array BioPharma Inc.
Tricia Haugeto
303-386-1193
thaugeto@arraybiopharma.com

SOURCE: Array BioPharma Inc.